Adhesion molecules |
e-selectin |
N/A |
Circulation |
Human |
Associated with microvascular EDD impairment |
(Lind, et al, 2008) |
Intracellular adhesion molecule |
ICAM |
Endothelial, circulation |
Human, rat, mouse |
Associated with impaired EDD (primarily microvascular), promotes leukocyte adhesion to endothelium |
(Csiszar, et al, 2009, Vita, et al, 2004a, Yepuri, et al, 2012) |
Vascular cell adhesion molecule |
VCAM |
Endothelial, circulation |
Human, mouse |
Associated with impaired cerebral blood flow, promotes leukocyte adhesion to endothelium |
(Tchalla, et al, 2015, Yepuri, et al, 2012) |
Cytokines & Chemokines |
Interferon-γ |
IFN-γ |
Whole artery |
Human, mouse |
Gene polymorphisms associated with CVD, EDD impairment |
(Annoni, et al, 2009, Lesniewski, et al, 2011, Stokes, et al, 2007) |
Interluekin-1β |
IL-1β |
Endothelial, whole artery, circulation |
Human, non-human primate, rat, mouse |
Major role in CVD |
(Csiszar, et al, 2003, Csiszar, et al, 2012, Lesniewski, Durrant, Connell, Henson, et al., 2011, Ridker, Paul M., et al, 2017) |
Interluekin-6 |
IL-6 |
Endothelial, circulation |
Human,rat |
Associated with CVD & large artery stiffness, role in impaired EDD |
(Csiszar, et al, 2003, Donato, et al, 2008, Schnabel, et al, 2008, Vita, et al, 2004b, Wassmann, et al, 2004) |
Interleukin-17 |
IL-17 |
Smooth muscle |
Rat |
EDD impairment |
(Csiszar, et al, 2003, Nguyen, et al, 2013) |
Interleukin-10 |
IL-10 |
Circulation, whole artery |
Human, mouse |
Low levels associated with CVD, large artery stiffness, EDD impairment |
(Freitas, et al, 2011, Kinzenbaw, et al, 2013) |
Transforming Growth Factor-β |
TGF-β |
Whole artery |
Mouse |
Collagen deposition, arterial stiffening |
(Fleenor, et al, 2010) |
Tumour Necrosis Factor-α |
TNF-α |
Endothelial, smooth muscle, circulation |
Human, rat, mouse |
Associated with CVD, impaired EDD, role in large artery stiffening |
(Belmin, et al, 1995, Csiszar, et al, 2003, Donato, et al, 2008, Machado-Silva, et al, 2016, Moreau, et al, 2013) |
CC motif chemokine ligand 2 |
CCL2, aka Monocyte Chemoattractant protein 1 |
Endothelial, Smooth muscle, perivascular adipose |
Human, mouse |
Leukocyte recruitment to artery, promotes large artery stiffening |
(Donato, et al, 2008, Wang, et al, 2007, Wang, et al, 2011) |
CC motif chemokine ligand 5 |
CCL5, aka RANTES |
Circulating |
Human, mouse |
Associated with CVD, may promote arterial stiffening |
(Grufman, et al, 2014, Lozhkin, et al, 2017) |
CXC motif chemokine ligand 2 |
CXCL2 |
Smooth muscle, perivascular adipose |
Mouse |
Recruitment of monocytes to the artery |
(Fleenor, et al, 2014, Song, et al, 2012) |
CXC motif chemokine ligand 10 |
CXCL10 |
Whole artery, smooth muscle |
Mouse |
Recruitment of T cells to the artery |
(Song, et al, 2012, Trott, et al, 2017) |
Granuolocyte Macrophage Colony Stimulating Factor |
GM-CSF |
Whole artery, perivascular adipose |
Mouse |
Macrophage recruitment to the artery |
(Fleenor, et al, 2014, Trott, et al, 2017) |
Immune cells |
B cells |
N/A |
Circulation, Perivascular adipose |
Mouse |
Infiltration of perivascular adipose |
(Trott, et al, 2018) |
T cells |
N/A |
Circulation, Perivascular adipose |
Human, mouse |
Proinflammatory cells associated with large artery stiffness, infiltration of perivascular adipose |
(Lesniewski, et al, 2011, Trott, et al, 2018, Yu, et al, 2017) |
Monocytes/ Macrophages |
N/A |
Circulation, Perivascular adipose |
Human, mouse |
Associated with EDD impairment, infiltration of perivascular adipose promote atherosclerosis |
(Du, et al, 2016, Lesniewski, et al, 2011, Trott, et al, 2018, Walker, et al, 2010) |
Neutrophils |
N/A |
Circulation, other? |
Human |
Associated with microvascular EDD impairment |
(Walker, et al, 2010) |
Transcription Factors |
Nuclear Factor κ B |
NFκB |
Endothelial, Smooth muscle |
Human, non-human primate, rodent |
Induces transcription of pro-inflammatory cytokines and chemokines and ROS producing enzymes. Associated with impaired flow mediated dilation and microvascular EDD impairment |
(Donato, et al, 2007, Donato, et al, 2008, Donato, et al, 2013, Rodríguez-Mañas, et al, 2009, Ungvari, et al, 2011) |
Nuclear factor (erythroid-derived 2)-like 2 |
Nrf2 |
Endothelial, smooth muscle |
Non-human primate, mouse |
Decrease in antoxidant and antiinflammatory gene expression, EDD impairment |
(Csiszar, et al, 2012, Fulop, et al, 2018, Ungvari, et al, 2011) |
Other |
Matrix Metalloproteinase 2 |
MMP2 |
Endothelial |
Human |
Elastin degradation, arterial stiffening |
(Wang, et al, 2007) |
Matrix Metalloproteinase 9 |
MMP9 |
Endothelial, whole artery |
Human, mouse |
Elastin degradation, arterial stiffening |
(Donato, et al, 2013, Wang, et al, 2007) |
Toll Like Receptor 4 |
TLR |
Smooth muscle |
Rat |
Upregulation of IL-6 production |
(Song, et al, 2012) |
C reactive protein |
CRP |
Circulation |
Human |
Associated with CVD & large artery stiffness, role in impaired EDD (primarily microvascular) |
(Fichtlscherer, et al, 2000, Hein, et al, 2009, Lind, et al, 2008, Mattace-Raso, et al, 2004) |